Atossa Genetics Return on Tangible Equity 2012-2024 | ATOS
Current and historical return on tangible equity values for Atossa Genetics (ATOS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Atossa Genetics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $-0.03B | $0.07B | -32.63% |
| 2024-06-30 | $-0.03B | $0.08B | -29.30% |
| 2024-03-31 | $-0.03B | $0.09B | -31.58% |
| 2023-12-31 | $-0.03B | $0.09B | -29.48% |
| 2023-09-30 | $-0.03B | $0.10B | -26.73% |
| 2023-06-30 | $-0.03B | $0.11B | -26.96% |
| 2023-03-31 | $-0.03B | $0.11B | -23.09% |
| 2022-12-31 | $-0.03B | $0.12B | -21.30% |
| 2022-09-30 | $-0.03B | $0.12B | -18.98% |
| 2022-06-30 | $-0.02B | $0.13B | -16.18% |
| 2022-03-31 | $-0.02B | $0.14B | -15.77% |
| 2021-12-31 | $-0.02B | $0.14B | -14.92% |
| 2021-09-30 | $-0.03B | $0.14B | -24.78% |
| 2021-06-30 | $-0.03B | $0.14B | -32.40% |
| 2021-03-31 | $-0.02B | $0.14B | -49.73% |
| 2020-12-31 | $-0.02B | $0.03B | -157.14% |
| 2020-09-30 | $-0.01B | $0.01B | -123.81% |
| 2020-06-30 | $-0.01B | $0.01B | -110.64% |
| 2020-03-31 | $-0.02B | $0.01B | -114.29% |
| 2019-12-31 | $-0.02B | $0.01B | -106.25% |
| 2019-09-30 | $-0.02B | $0.02B | -106.67% |
| 2019-06-30 | $-0.02B | $0.02B | -114.29% |
| 2019-03-31 | $-0.03B | $0.02B | -188.68% |
| 2018-12-31 | $-0.02B | $0.01B | -235.90% |
| 2018-09-30 | $-0.02B | $0.01B | -248.65% |
| 2018-06-30 | $-0.02B | $0.01B | -314.29% |
| 2018-03-31 | $-0.01B | $0.01B | -275.00% |
| 2017-12-31 | $-0.01B | $0.01B | -366.67% |
| 2017-09-30 | $-0.01B | $0.00B | -685.71% |
| 2017-06-30 | $-0.01B | $0.00B | -444.44% |
| 2017-03-31 | $-0.01B | $0.00B | -350.00% |
| 2016-12-31 | $-0.01B | $0.00B | -311.11% |
| 2016-09-30 | $-0.01B | $0.00B | -400.00% |
| 2016-06-30 | $-0.01B | $0.00B | -433.33% |
| 2016-03-31 | $-0.01B | $0.00B | -254.55% |
| 2015-12-31 | $-0.02B | $0.00B | -214.29% |
| 2015-09-30 | $-0.02B | $0.01B | -188.24% |
| 2015-06-30 | $-0.02B | $0.01B | -157.89% |
| 2015-03-31 | $-0.02B | $0.01B | -146.34% |
| 2014-12-31 | $-0.01B | $0.01B | -112.00% |
| 2014-09-30 | $-0.01B | $0.01B | -91.67% |
| 2014-06-30 | $-0.01B | $0.01B | -109.09% |
| 2014-03-31 | $-0.01B | $0.02B | -141.18% |
| 2013-12-31 | $-0.01B | $0.01B | -252.63% |
| 2013-09-30 | $-0.01B | $0.01B | -314.29% |
| 2013-06-30 | $-0.01B | $0.00B | -533.33% |
| 2013-03-31 | $-0.01B | $0.00B | -1200.00% |
| 2012-12-31 | $-0.01B | $0.00B | inf% |
| 2012-06-30 | $-0.00B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.153B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.393B | 24.93 |
| Intuitive Surgical (ISRG) | United States | $193.619B | 101.23 |
| Edwards Lifesciences (EW) | United States | $43.533B | 27.64 |
| Alcon (ALC) | Switzerland | $42.700B | 28.57 |
| IQVIA Holdings (IQV) | United States | $36.494B | 20.11 |
| IDEXX Laboratories (IDXX) | United States | $35.790B | 42.15 |
| DexCom (DXCM) | United States | $31.431B | 47.33 |
| Waters (WAT) | United States | $22.876B | 33.83 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.760B | 0.00 |
| Hologic (HOLX) | United States | $17.141B | 18.51 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.008B | 14.38 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.294B | 28.60 |
| Penumbra (PEN) | United States | $9.735B | 95.36 |
| Masimo (MASI) | United States | $9.336B | 45.18 |
| Teleflex (TFX) | United States | $8.528B | 13.60 |
| Glaukos (GKOS) | United States | $7.879B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.728B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.717B | 26.73 |
| Inari Medical (NARI) | United States | $3.408B | 0.00 |
| Veracyte (VCYT) | United States | $3.372B | 101.19 |
| LivaNova (LIVN) | United Kingdom | $2.796B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.337B | 17.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.267B | 0.00 |
| TransMedics (TMDX) | United States | $2.261B | 71.66 |
| Elekta AB (EKTAY) | Sweden | $2.229B | 20.04 |
| Integra LifeSciences Holdings (IART) | United States | $1.864B | 9.74 |
| RxSight (RXST) | United States | $1.515B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.254B | 83.11 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.062B | 0.00 |
| Paragon 28 (FNA) | United States | $0.874B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.708B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 16.49 |
| IRadimed (IRMD) | United States | $0.699B | 37.80 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.558B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 31.48 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.453B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.440B | 23.83 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.331B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.230B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.162B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.12 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.011B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |